They were averaging $200k QoQ last year and looks like $400k is new QoQ this year so they should be able to cover OPEX and be CF+ in near term quite easily.
Ex RESMED CFO (Carl) just joined - judging by his LINKEDIN I would say he did a pretty good job at RESMED as he was there for several years and promoted internally.
I have noticed a few competitors coming into this 3D printing space, I am working on a market analysis report if anyone would like a copy, let me know.
OSX is very well positioned to become a market leader thanks to our long history of clinical data. New entrants face a long pathway into this space (clinical studies, regulatory approvals etc). Personalised implants is a booming segment in the orthopaedic industry. Patience and accumulation will pay off here in my opinion.
Ann: Activities Update Qtr Ending December 2020 and Appendix 4C, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.002(15.4%) |
Mkt cap ! $3.107M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.4¢ | $13.82K | 944.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 648717 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 1027816 | 5 |
View Market Depth
| Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
| OSX (ASX) Chart |
Day chart unavailable